Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
PHAR Pharming Group
9.840
-0.850-7.95%
YOY
Do not show
Hide blank lines
(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31
Total revenue
0.81% 50.15M 10.33% 46.62M -12.93% 198.87M -34.86% 45.75M
Operating revenue
0.81% 50.15M 10.33% 46.62M -12.93% 198.87M -34.86% 45.75M
Cost of revenue
-13.6% 4.03M 3.82% 4.88M -16.56% 21.14M -39.53% 4.89M
Gross profit
2.3% 46.12M 11.15% 41.74M -12.47% 177.73M -34.26% 40.86M
Operating expense
-17.38% 28.3M 23.69% 38.92M 31.21% 158.72M 5.27% 42.22M
Selling and administrative expenses
28.02% 27.95M 16.84% 24.93M 16.76% 81.7M 59.66% 25.89M
-Selling and marketing expense
38.36% 19.25M 19.52% 17.2M 7.01% 59.45M -24.35% 13.5M
-General and administrative expense
9.84% 8.69M 11.28% 7.73M 54.32% 22.25M 859.79% 12.39M
Research and development costs
6.87% 14.43M 43.21% 14.86M 69.71% 70.37M 26.07% 17.03M
Depreciation amortization depletion
-- -- -- -- -30.39% 857K -- --
-Depreciation and amortization
-- -- -- -- -30.39% 857K -- --
Other operating expenses
-1197.25% -14.08M -247.99% -873K -30.19% 5.8M -107.66% -701K
Operating profit
64.56% 17.82M -53.64% 2.83M -76.84% 19.01M -106.19% -1.36M
Net non-operating interest income expense
-16.98% -4.63M -70.94% 1.85M 252.57% 8.71M -81.41% 2.8M
Non-operating interest income
-24.75% -3.23M -59.21% 3.23M -93.12% 53K 4796.11% 4.3M
Non-operating interest expense
-1.41% 1.35M -11.02% 1.38M -4.8% 6.09M 109.93% 1.5M
Total other finance cost
-- -- -- -- -18546% -14.75M -- --
Other net income (expense)
1239.3% 6.37M -774.85% -441K 83.96% -4.64M 100.7% 205K
Gain on sale of security
-- -- -- -- 100.55% 114K 100.23% 47K
Earnings from equity interest
-123.61% -109K -453.22% -441K 78% 694K -1.84% 158K
Special income (charges)
-- -- -- -- 37.2% -5.45M -- --
-Less:Restructuring and merger&acquisition
-- -- -- -- -- 0 -- --
-Less:Impairment of capital assets
-- -- -- -- -- 5.45M -- --
Income before tax
166.07% 19.56M -65.88% 4.23M -51.38% 23.08M -78.98% 1.64M
Income tax
161.99% 3.82M -81.36% 772K 3.63% 7.08M 92.14% -217K
Net income
167.07% 15.74M -58.13% 3.46M -60.63% 16M -82.41% 1.86M
Net income continuous Operations
167.07% 15.74M -58.13% 3.46M -60.63% 16M -82.41% 1.86M
Minority interest income
Net income attributable to the parent company
167.07% 15.74M -58.13% 3.46M -60.63% 16M -82.41% 1.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
167.07% 15.74M -58.13% 3.46M -60.63% 16M -82.41% 1.86M
Basic earnings per share
147.04% 0.24 -61.23% 0.05 -60.15% 0.25 -80.97% 0.03
Diluted earnings per share
258% 0.22 -61.23% 0.05 -61.04% 0.23 -80.97% 0.03
Dividend per share
Currency Unit
USDUSDUSDEUR
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
----Unqualified Opinion with Explanation--

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
CEO: --
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top